The lac operon in uropathogenic Escherichia coli enhances intracellular growth by enabling host glycan utilization https://www.biorxiv.org/content/10.64898/2025.12.03.691977v1
04.12.2025 03:16 β π 3 π 1 π¬ 0 π 0@arzamasovalex.bsky.social
Postdoc in Osterman lab at SBP Medical Discovery Institute. Interested in the functional annotation of genomic and metagenomic data, carbohydrate metabolism, #bifidobacteria
The lac operon in uropathogenic Escherichia coli enhances intracellular growth by enabling host glycan utilization https://www.biorxiv.org/content/10.64898/2025.12.03.691977v1
04.12.2025 03:16 β π 3 π 1 π¬ 0 π 0Glycoside hydrolaseβmediated glucomannan catabolism in Segatella copri, a target of microbiota-directed foods for malnourished children
www.pnas.org/doi/10.1073/...
Have a look if you are interested in how the team at @cultivarium.bsky.social is finding electroporation protocols for new microbes: both screening lots of conditions on a custom built electroporator concurrently, and cyclical iteration using bayesian optimization
www.biorxiv.org/content/10.1...
Overall, given that FOS are often included in infant formulas and used widely as prebiotics, itβs important to understand the mechanisms by which microbes utilize these oligosaccharides of different chain lengths
16.11.2025 01:48 β π 1 π 0 π¬ 0 π 0We observed a similar pattern in Bifidobacterium: only strains carrying a specific ABC transporter could metabolize long-chain FOS, while utilization of short-chain FOS was broadly conserved
www.nature.com/articles/s41...
Very cool print demonstrating how variation in at TonB-dependent transporter repertoires shapes the ability of Bacteroides and Phocaeicola species to utilize fructooligosaccharides (FOS) of different chain lengths
16.11.2025 01:48 β π 12 π 7 π¬ 1 π 0Some cool data on bifidobacteria and their relatives in honeybees!
14.10.2025 21:48 β π 0 π 0 π¬ 0 π 0Happy to announce that our comparative metagenomic analysis of the gut microbiota of five honeybee species - spearheaded by @aiswarya.bsky.social - is finally published in a peer-reviewed journal! rdcu.be/eKMCs @fbm-unil.bsky.social @dmf-unil.bsky.social π§΅π
14.10.2025 19:04 β π 62 π 22 π¬ 1 π 2Genomic studies in bifidobacteria often focus only on CAZymes. IMHO, in Gram-positives, transporters are the true gatekeepers of glycan metabolism. We need to prioritize improving their functional annotations and include them in metabolic reconstructions (7/7)
30.09.2025 09:01 β π 1 π 0 π¬ 0 π 0We demonstrated that phylogenetically closely related strains can exhibit substantial differences in HMO utilization, which is driven by subtle variations in HMO transporter genes. Species/subspecies names alone donβt tell the full story; one needs to look at gene content in individual strains(6/7)
30.09.2025 09:01 β π 0 π 0 π¬ 1 π 0Among the new pathways we uncovered was a xyloglucan degradation pathway that was present in rare B. catenulatum subsp. kashiwanohense strains and conserved in B. dentium and B. tsurumiense (5/7)
30.09.2025 09:01 β π 0 π 0 π¬ 1 π 0We validated phenotypic predictions for 30 bifidobacterial strains, achieving 94% accuracy. For example, we confirmed the unique ability of the new B. longum clade to grow on starch and pullulan, and described an unconventional B. adolescentis strain that can use 2β-fucosyllactose (4/7)
30.09.2025 09:01 β π 0 π 0 π¬ 1 π 0Our analysis revealed notable inter- and intra-species variability. Among notable findings was a new Bifidobacterium longum clade harboring pathways for starch, pullulan, and difructose dianhydride metabolism but lacking pathways for LNB/GNB, N-glycan, and human milk oligosaccharide utilization(3/7)
30.09.2025 09:01 β π 0 π 0 π¬ 1 π 0We reconstructed 68 glycan utilization pathways encoded in 3,083 bif genomes by looking at the distribution of 589 curated metabolic functions (transporters, CAZymes, etc). Several years of manual curation greatly improved the quality of functional gene annotations (>90% for transporters!) (2/7)
30.09.2025 09:01 β π 0 π 0 π¬ 1 π 0Itβs been a bit over 2 months since the main results of my PhD work on reconstructing carbohydrate utilization pathways in human bifidobacteria were finally published; so I guess itβs a good time to update the previous thread (1/7) www.nature.com/articles/s41...
30.09.2025 09:01 β π 3 π 1 π¬ 1 π 0Among the new pathways we uncovered was a xyloglucan degradation pathway that was present in rare B. catenulatum subsp. kashiwanohense strains and conserved in B. dentium and B. tsurumiense (5/7)
30.09.2025 08:49 β π 0 π 0 π¬ 0 π 0We validated phenotypic predictions for 30 bifidobacterial strains, achieving 94% accuracy. For example, we confirmed the unique ability of the new B. longum clade to grow on starch and pullulan, and described a B. adolescentis strain that can use 2β-fucosyllactose (4/7)
30.09.2025 08:49 β π 0 π 0 π¬ 1 π 0Our analysis revealed notable inter- and intra-species variability. Among notable findings was a new Bifidobacterium longum clade harboring pathways for starch, pullulan, and difructose dianhydride metabolism but lacking pathways for LNB/GNB, N-glycan, and human milk oligosaccharide utilization(3/7)
30.09.2025 08:49 β π 0 π 0 π¬ 1 π 0We reconstructed 68 glycan utilization pathways encoded in 3,083 bif genomes by looking at the distribution of 589 curated metabolic functions (transporters, CAZymes, etc). Several years of manual curation greatly improved the quality of functional gene annotations (>90% for transporters!) (2/7)
30.09.2025 08:49 β π 0 π 0 π¬ 1 π 0Excited to share our @cp-cellhostmicrobe.bsky.social led by Magda showing how Bif has co-evolved with different animal hosts πππ·π¦
Key takeaways:
πΉ Host ancestry + diet shape Bif evolution
πΉ Mammals enriched for carb-busting enzymes
πΉ Untapped diversity in non-human hosts = new probiotic potential
Our study developing a skin metatranscriptomics protocol is now out in @natbiotech.nature.com!
We finally have the ability to study microbial activity on skin and identify key functional genes playing a role in diseases.
Amazing team of Chia Minghao and Amanda Ng π
nature.com/articles/s41...
Very nice paper that deciphers the transport mechanisms of fucosylated lacto-N-biose in Bifidobacterium longum subsp. infantis
journals.asm.org/doi/full/10....
High-throughput single-cell isolation of Bifidobacterium strains from the gut microbiome https://www.biorxiv.org/content/10.1101/2025.07.23.666462v1
25.07.2025 04:17 β π 4 π 3 π¬ 0 π 0Thanks! Also, maybe of interest, I think PSORTb and the new tool DeepLocPro perform better for bifido proteins than signalP
academic.oup.com/bioinformati...
4) The GH136 lacto-N-biosidase from B. longum that you cite does not release LacNAc from Lacto-N-neotetraose (Fig. 4b from Sakurama et al). The B. bifidum GH136 is not identical to the B. longum one, but I haven't seen papers describing activity on LNnT (only LNT)
www.jbc.org/article/S002...
3) Additionally, B. bifidum possesses an ortholog of an ABC transporter that can uptake GNB (GltABC), so it would make sense for the GH101 enzyme to be extracellular, so the released disaccharide is then imported.
www.jbc.org/article/S002...
2) Your predictions about the localization of some other GHs (like GH89 and GH101) also differ from previously published literature. For example, the GH89 was described as a membrane-anchored extracellular enzyme before.
link.springer.com/article/10.1...
Hi, very cool to see this out! I have a couple of comments about the model. 1) I think the GH20 enzyme that removes GlcNAc-6S (BbhII) is extracellular. The released GlcNAc-6S can be cross-fed to Bifidobacterium breve (some strains have a dedicated utilization pathway)
doi.org/10.1080/0916...
3) Additionally, B. bifidum possesses an ortholog of an ABC transporter that can uptake GNB (GltABC), so it would make sense for this GH89 to be extracellular, so the released disaccharide is then imported.
www.jbc.org/article/S002...
New Pre-print! βPNGaseA-mediated N-glycan stripping from peptides by infant-derived Bifidobacterium bifidumβ. This is the first manuscript from the Bifidobacterium and breast milk projectπΌπ€±πΆin collaboration with van Sinderen and Lovering groups
www.biorxiv.org/content/10.1...